Background:
The SLE-key ® test was developed by ImmunArray and was validated to rule out SLE with 94% sensitivity, 75% specificity and a negative predictive value (NPV) of 93% 1 . We reported earlier that the SLE-key ® RuleOut test could aid in the diagnosis and disposition of a cohort of 55 patients in our clinical practice 2 . Objectives: We have now expanded this cohort and report here the usefulness of the SLE-key ® test in aiding the management of a cohort of challenging and suspected SLE patients in a large clinical practice. Methods: In patients referred to the Rheumatology and Immunotherapy Center, in Franklin, WI, results from the SLE-key ® RuleOut test were included as part of the clinical evaluation. Serum samples were collected from individual subjects with informed consent and tested at VERACIS (Richmond, VA), using the SLE-Key ® iCHIP ®1 . Results: We reviewed the diagnoses and clinical disposition of patients both before and after SLE-key ® testing. In particular, we looked at the ability of the SLE-key ® test to enhance our ability to reach a definitive diagnosis across the full cohort of patients, at the disposition of patients who were referred with a suspicion of SLE as part of the differential diagnosis, at the impact of SLE-key ® testing on the diagnosis of the subset of patients who presented with minimal symptoms, and at the group of patients who had been referred following an ANA test. Results are summarized in Table 1 . In the cases where SLE was ruled out, patients were treated for a variety of disorders including fibromyalgia, joint pain, MCTD, Sjogren's disease and others. Background: Infection is an important cause of morbidity and mortality in patients with systemic lupus erythematosus (SLE). The spectrum of infectious agents in SLE patients varies significantly among different ethnic groups. The national surveillance study from the China showed that Gram-negative bacteria (GNB) was the most the common bacterial infection in China, while Gram-positive bacteria (GPB) was predominant in European countries. Objectives: To identify the spectrum and drug resistant pattern of infection caused by GNB in patients hospitalized with SLE.
Methods:
The clinical and microbiological data from hospitalized SLE patients with bacterial infection between June 2005 and June 2015 was collected and then analyzed retrospectively. Results: Two hundred and sixty-eight episodes of bacteria had been identified from 3815 hospitalized patients. In terms of isolated microorganisms, gramnegative bacteria (GNB) were predominant over gram-positive bacteria (GPB) (178 isolates vs. 90 isolates). In the GNB, Escherichia coli (66/178, 37.1%) was the most common isolate, followed by Acinetobacter baumannii (36/178, 20.2%), Klebsiella pneumoniae (24/178, 13.5%), Pseudomonas aeruginosa (20/178, 11.2%), Haemophilus influenzae (10/178,5.6%), Salmonella sp. (7/178, 3.9%), Enterobacter aerogenes (5/178, 2.8%), Stenotrophomonas maltophilia (5/178, 2.8%), Citrobacter freundii (3/178,1.7%), Proteus mirabilis (2/178,1.1%). Resistant isolates (53/178, 30.0%) were more common documented in GNB, mostly extended-spectrum beta-lactamase (ESBL) producing Escherichia coli (30/66, 45.5%) and Klebsiella pneumonia (6/24, 25%), and multi-drug resistant acinetobacter baumannii (36.1%). Susceptibility tests showed that the ESBLproducing strains were highly sensitive to carbapenems, β-lactamase inhibitor compound families, and certain cefalosporin (Cefepime and Ceftazidime) in vitro.
(the resistance rate <20%), whereas it was highly resistant to ampicillin and Gentamicin. Besides carbapenems and Cefoperazone/sulbactam, Acinetobacter baumannii was resistant to most antibiotics. Conclusions: GNB was predominant in Chinese hospitalized patients with SLE. The drug resistance of GNB has increased significantly. It was necessary to rational use of antibiotics in patients with SLE. Background: Renal involvement is a common and serious manifestation of SLE. Hyperuricemia may be associated with lupus nephritis as a result of renal damage. However, it is not yet well known whether hyperuricemia is independently associated with renal involvement even in patients without known predisposing factors for hyperuricemia such as decreased renal function, old age, male gender, menopause, and drugs. Objectives: The aim of this study was to evaluate the association of baseline serum uric acid level and development of nephritis in patients diagnosed with SLE. Methods: We retrospectively reviewed electronic medical records of 101 female SLE patients whose ages at the time of diagnosis (baseline) were 45 years old or below in a tertiary medical center from January 2000 to March 2015. SLE with renal involvement was diagnosed when patients met the renal disorder of the 1997 ACR criteria for SLE. We compared baseline serum uric acid levels of the SLE patients who had nephritis at the time of diagnosis or later (nephritis group) with the patients who had not developed nephritis (non-nephritis group) during follow-up period. Results: Among 101 patients, 22 (22%) had hyperuricemia (serum uric acid ≥6 mg/dL) at baseline and 45 (45%) had developed nephritis during follow-up period (median 6.1 years). There were significant differences in baseline serum uric acid level, glomerular filtration rate (GFR), anti-dsDNA antibody and complement level between non-nephritis group and nephritis group (Table) . Interestingly, among 59 patients with normal renal function (baseline GFR ≥90 mL/min/1.73m
2 ), baseline serum uric acid level was also significantly higher in the nephritis group than non-nephritis group (Table) . Moreover, the patients with hyperuricemia at baseline were more likely to develop nephritis than those without hyperuricemia during follow-up period (64% vs. 39%, p =0.042) (Figure) . Background: Although there are many defence systems that protect cellular macromolecules against oxidation, oxidative DNA and RNA damage still occurs.
Oxidative damage to nucleic acids has been found to be associated with etiopathogenesis and disease activity of inflammatory disorders. Oxidised guanine species have been recognized as a biomarker of oxidative DNA and RNA damage by endogenously generated oxygen radicals. Sjögren's syndrome (SS) is an autoimmune disorder and associated with overexpression of proinflammatory cytokines. Related to excess expression of proinflammatory cytokines, a prooxidant state could be postulated in SS. Objectives: We aimed to evaluate levels of nucleic acids oxidative stress products in patients with SS. Methods: 11 patients with SS diagnosed according to 2012 American College of Rheumatology (ACR) Classification Criteria for Sjögren's Syndrome, 19 patients with psoriatic arthritis (PsA), diagnosed according to Classification Criteria for Psoriatic Arthritis (PSARC), 9 patients with rheumatoid arthritis (RA), diagnosed according to 2010 Rheumatoid Arthritis Classification Criteria, and 12 healthy controls were included. All SS patients were on hydroxychloroquine sulphate 400mg/day. All PsA and RA patients were on methotrexate 15-20mg/week and folic acid 5 mg/week. The serum samples were collected from participants and stored at -30 C until assayed. Three oxidised guanine species, 8-hydroxy-2'-deoxyguanosine as a DNA oxidation marker, 8-hydroxyguanosine as a RNA oxidation marker, and 8-hydroxyguanine as a DNA and RNA oxidation marker, were measured using DNA/RNA Oxidative Damage ELISA Kit (Cayman Chemicals, USA). Statistics: All data are presented as mean and standard deviation (SD). Differences between groups were examined using Kruskal-Wallis tests. The Mann-Whitney U test was performed to test the significance of pairwise differences using Bonferroni correction to adjust for multiple comparisons. A p-value less than 0.05 were considered as statistically significant. Statistical analysis of correlation was performed by using the Spearman rank test. Results: There was no statistically significant difference between the groups in terms of age and gender. The average level of serum oxidised guanine species in the PsA, RA, SS and healthy control groups were 2871. 77±336.20, 2672.20±292.04, 3375.57±344.21, 2777 .55±237.05 pg/mL respectively. Oxidised guanine species levels were significantly higher in patients with SS and positively correlated with CRP levels (p:0.011, r: 0.726) (table 2).
Conclusions:
A marked increase in DNA damage leading to oxidative stress may contribute to tissue damage in SS. Disclosure of Interest: None declared DOI: 10.1136/annrheumdis-2017-eular.3286 
